quinaprilat has been researched along with neostigmine bromide in 2 studies
Studies (quinaprilat) | Trials (quinaprilat) | Recent Studies (post-2010) (quinaprilat) | Studies (neostigmine bromide) | Trials (neostigmine bromide) | Recent Studies (post-2010) (neostigmine bromide) |
---|---|---|---|---|---|
92 | 23 | 4 | 43 | 0 | 16 |
Protein | Taxonomy | quinaprilat (IC50) | neostigmine bromide (IC50) |
---|---|---|---|
Acetylcholinesterase | Electrophorus electricus (electric eel) | 0.0594 | |
Acetylcholinesterase | Homo sapiens (human) | 0.1112 | |
Acetylcholinesterase | Rattus norvegicus (Norway rat) | 0.9813 | |
Cholinesterase | Equus caballus (horse) | 0.07 | |
Muscarinic acetylcholine receptor | Cavia porcellus (domestic guinea pig) | 0.045 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
2 other study(ies) available for quinaprilat and neostigmine bromide
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |